[Retinoids in oncology].
Klinische Forschung, Hofmann-La Roche AG, Grenzach-Wyhlen.
J
J
Kiemle-Kallee
F
F
Porzsolt
D002352:Carrier Proteins / Q000494:pharmacology; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy; D009190:Myelodysplastic Syndromes / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D018168:Receptors, Retinoic Acid; D012176:Retinoids / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D013723:Teratogens; D014212:Tretinoin / Q000494:pharmacology
D002352:Carrier Proteins; D018168:Receptors, Retinoic Acid; D012176:Retinoids; D013723:Teratogens; D014212:Tretinoin